Menu
Yellowbird Diagnostics

Illuminating the opportunity for a cure

ABOUT YELLOWBIRD

What we do

Yellowbird Diagnostics develops plug-and-play imaging dyes for common medical imaging procedures. Our solutions enable better diagnostic imaging for patients with the greatest need for early diagnosis of diseases of the brain, heart and kidneys. Our products reveal otherwise invisible hallmarks of disease, empowering clinicians to make earlier and more effective medical decisions.
The Technology

Advanced medical imaging agents that provide molecular information about disease.

NeuCaVis™
NeuCaVis™
A PET dye that can better identify diseases in the heart and brain earlier and more accurately than the current clinical standard.
FilTrak™
FilTrak™
A metal-free MRI dye platform capable of mapping kidney function in patients that go unscanned due to risks associated with the existing MRI dyes.
Aurogami™
Aurogami™
A first-in-class nanomaterial-based dye platform for identifying previously invisible markers of cardiac and vascular inflammation using interventional cardiology workflows.
The Team

Meet Our Experienced Team Members

Nicholas D. Calvert, PhD
Nicholas D. Calvert, PhD
Co-Founder, Chief Executive Officer
Alexia Kirby, PhD
Alexia Kirby, PhD
Co-Founder, Chief Operations Officer
Adam Shuhendler, PhD
Adam Shuhendler, PhD
Co-Founder, Chief Scientific Officer
Supported By

We have a great group of supporters and investors

BHI
CAN
CMIE
ElevateIP
FACIT
Innovation Factory
Invest Ottawa
OntarioBIO
uOttawa
StartupGarage
Capital Bioventures
Centre for Probe Development an Commercialization
District 3
Ontario Brain Institute
H2i
ECHO
Media

What's happening in the Media

LinkedIn
Entrepreneurship or Cardiovascular Health Opportunities (ECHO) announces 2024-2025 cohort
Ontario Brain Institute
Propelling neurotech innovation: OBI awards $700K in entrepreneurial funding support
uOttawa
The gold standard: uOttawa researchers revolutionize cardiology imaging using gold nanoparticles
CMIE
Canadian Medical Isotope Ecosystem Selects Five Programs to Receieve over $1.7M in Funding
CTVNews
uOttawa researchers develop new radiotracer to detect a wider range of diseases in their early stages
SNMMI
Novel PET Tracer Maps Fructose Metabolism to Identify Cardiac and Neural Disorders
BioTechniques
Radiotracer illuminates fructose metabolism
Applied Radiation Oncology
New PET Radiotracer Maps Fructose Metabolism to Detect Diseases
uOttawa
uOttawa scientists develop novel radiotracer for earlier detection of disease
uOttawa
New kidney MRI dye promises more accurate, personalized mapping
HiE
Metal-free kidney MRI dye for more personalized diagnostics
MedicalXpress
New kidney MRI dye promises more accurate, personalized mapping